Theseus Pharmaceuticals (THRX) Earnings Report - Discounting Cash Flows
Theseus Pharmaceuticals, Inc.
THRX (NASDAQ)

* (except for per share items) of USD
Period Ending: 2024
08-10
2024
05-11
2024
03-14
2023
11-17
2023
08-10
2023
05-11
2023
03-09
2022
11-03
2022
08-11
2022
05-12
2022
03-10
2021
11-15
2021
06-30
2021
03-31
2020
12-31
2020
09-30
Actual EPS - - -0.35 -0.31 -0.34 -0.34 -0.35 -0.38 -0.30 -0.27 -0.24 -5.16 -0.19 -0.18 -0.11 -0.06
Estimated EPS - - -0.33 -0.35 -0.34 -0.42 -0.44 -0.34 -0.29 -0.25 -0.23 -0.24 - - - -
Actual Revenue - - - - - - - - - - - - - - - -
Estimated Revenue - - - - - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us